TotalMarketCap

Lb Pharmaceuticals

LBRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.229 B

$38.10 -6.73%

Close of 6 Nov 2026

As of 6 Nov 2026, Lb Pharmaceuticals (LBRX) has a market capitalization of $1.23B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$25.2M

Loss-making

Shares outstanding

32,363,040

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #134Nektar TherapeuticsNKTR$1.24B
  2. #135OmerosOMER$1.24B
  3. #136Lb PharmaceuticalsLBRX$1.23B
  4. #137Silence TherapeuticsSLN$1.23B
  5. #138MannkindMNKD$1.21B

What if Lb Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$875,312.96

Per share 22,974× higher

Bitcoin $1.53T

$47,361.66

Per share 1,243× higher

Apple $5.02T

$155,483.91

Per share 4,081× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Lb Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.